Back to today’s briefing

Story perspectives

Unlocking Genetic Insights to Revolutionize CAD Treatments

10/8/2025

40 7

Summary

Story summary

Large-scale genome-wide association studies (GWAS) are advancing understanding of coronary artery disease (CAD) and related genetic factors.
Functional characterization of genetic variants is needed to improve treatments for CAD and type 2 diabetes (T2D).
Sex differences affect CAD presentation and management, while single-cell epigenomics and genomic-data integration advance personalized cardiovascular care.

1 of 1

Story summary

Large-scale genome-wide association studies (GWAS) are advancing understanding of coronary artery disease (CAD) and related genetic factors.
Functional characterization of genetic variants is needed to improve treatments for CAD and type 2 diabetes (T2D).
Sex differences affect CAD presentation and management, while single-cell epigenomics and genomic-data integration advance personalized cardiovascular care.